Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Study of the Analgesic Efficacy and Safety of Flexible Dose Q8003 Versus Low Dose Q8003 in Patients Who Have Undergone Primary Unilateral Total Knee Arthroplasty
Conditions
Interventions
Flexible dose Q8003 (morphine sulfate and oxycodone hydrochloride)
Low dose Q8003 (morphine sulfate and oxycodone hydrochloride)
Locations
11
United States
Investigator Site
Birmingham, Alabama, United States
Investigator Site
Sheffield, Alabama, United States
Investigator Site
Phoenix, Arizona, United States
Investigator Site
Laguna Hills, California, United States
Investigator Site
Long Beach, California, United States
Investigator Site
Pasadena, California, United States
Start Date
February 1, 2010
Primary Completion Date
December 1, 2010
Completion Date
December 1, 2010
Last Updated
May 17, 2012
NCT06862609
NCT07327463
NCT07436806
NCT07442721
NCT07440940
NCT07413055
Lead Sponsor
QRxPharma Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions